Radio Frequency Identification in the Pharmaceutical Sector 9/2/2005 9:00:04 AM
DUBLIN, Ireland, Sep 02, 2005 (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/reports/c23609) has announced the addition of RFID in the Pharmaceutical Sector (2005) to their offering.
The RFID (Radio Frequency Identification) technology has generated a lot of interest in the present times. Most of the pharmaceutical companies have turned to the RFID technology to keep a tab on the cases of drug counterfeit and faulty medical equipment. The market research report "RFID in Pharmaceutical Sector (2005)" gives an in-depth analysis of RFID in Pharmaceutical Sector. The research report also examines the important reasons and benefits that are driving the pharmaceutical companies to adopt and implement RFID systems.
Applications of RFID systems in the pharmaceutical sector took off in 2004 due to the FDA (Food and Drug Administration) endorsements, impending pedigree laws (for administering the pedigree drugs) and Wal-Mart mandate (to implement RFID applications in their stores). Due to these reasons, the worldwide RFID market has grown tremendously and has a promising future.
The pharmaceutical companies had suffered a loss of $2 billion due to overstocking and expirations. More than that, the companies have lost more than $30 billion due to drug counterfeiting. The pharmaceutical makers, distributors, and retailers have now taken up RFID systems to enhance the data driven supply chain visibility and information sharing solutions. Tracking counterfeit drugs and medicines can be done easily.
FDA has recommended RFID tracking in pharmaceutical supply chain and state governments in the U.S. by 2007; that includes verification of drug shipments from manufacturer to retailer. This market research report discusses the current trends in the RFID market, RFID revenue, drug tracking and retailing, and the future forecasts. The emerging technologies, policies, and investments in the RFID projects are also highlighted.